Beyond acute inflammatory cascades, IL-6 has recently gained attention as a potential biomarker of the chronic inflammation that contributes to the development of diabetes or obesity (30, 31), but the potential for maternal diabetes to impact perinatal development through exposure to IL-6 has not been defined. This evidence concerns the gene IL6 and obesity disorder.